Radiotherapy for Prostate Cancer: 2- vs 8-Week Course

The phase III HYPO-RT-PC trial shows that a 2-week course of radiotherapy for localized prostate cancer is as safe and effective as the traditional 8-week schedule, even 10 years after treatment. The study's long-term findings confirm that the shorter course does not compromise outcomes and safety and offers potential benefits for patients and health systems.